To identify the specific T cell subset that play a major role in the anti-tumor activity, we performed depletion studies using anti-CD4 and anti-CD8 antibodies to selectively deplete CD4+ T and CD8+ T cells, respectively (Fig. 8E). The gene discussed is CD4; the disease is neoplasm.